NordiPenMate® - Quick Guide
Novo Nordisk country sites
USA
Argentina
Australia
Austria
Belgium
Brazil
Bulgaria
Canada
Chile
China
Croatia
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Greece
Hungary
India
Iraq
Ireland
Israel
Italy
Japan
Korea (Republic)
Latvia
Lebanon
Lithuania
Mexico
Netherlands
New Zealand
Norway
Pakistan
Poland
Portugal
Romania
Russian Federation
Serbia
Slovak Republic
Slovenia
South Africa
Spain
Sweden
Switzerland
Syria
Taiwan
Thailand
Turkey
Ukraine
United Kingdom
Other Novo Nordisk sites
Changing diabetes
DAWN study
Hagedorn Research Institute
Diabetes4Patients
Diabetes Barometer
Changing diabetes bus
Media prize
World diabetes day
School challenge
Improve Control
HRT for HCPs
HRT for women
HRT congresses & symposia
Healthcare Professionals
Patients
Investors
Media
R&D
Jobs
Sustainability
About us
Overview
Phamaceutical information
What is growth hormone?
Injection devices
Choosing the right device
NordiFlex®
NordiFlex PenMate®
NordiPen®
NordiPenMate®
NordiLet®
Needles
NovoFine®
Growth disorders
GHD (Growth hormone deficiency)
GHDA (Growth hormone deficiency in adults)
SGA (Small for gestational age)
Turner syndrome
Noonan syndrome
Skeletal dysplasia
Chronic renal insufficiency
Programmes & support
Interactive tutorial
Patient organisations
Our partnership with Save the Children
Rate this page
Send to a friend
Print
Quick guide
Back to top
